AMY LEWIS: Open Payments
NPI 1134586290 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 49 payments from 20 companies in 2025. Trend: 2023 $1,086 · 2024 $1,192 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $164 |
| ABBVIE INC. | 12 | $161 |
| Corcept Therapeutics | 3 | $88 |
| Novo Nordisk Inc | 4 | $74 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| Lilly USA, LLC | 3 | $58 |
| PFIZER INC. | 3 | $48 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Astellas Pharma US Inc | 2 | $44 |
| Biogen, Inc. | 2 | $36 |
Products named: JOT DX, Korlym, VRAYLAR, TRELEGY ELLIPTA, Veozah, UBRELVY, Wegovy, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
